DAM
Derbend Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-6,171
| Closed | -$210K | – | 97 |
|
2023
Q2 | $210K | Buy |
+6,171
| New | +$210K | 0.14% | 76 |
|
2022
Q4 | – | Sell |
-7,602
| Closed | -$250K | – | 77 |
|
2022
Q3 | $250K | Sell |
7,602
-280
| -4% | -$9.21K | 0.2% | 67 |
|
2022
Q2 | $248K | Sell |
7,882
-6,482
| -45% | -$204K | 0.21% | 61 |
|
2022
Q1 | $880K | Hold |
14,364
| – | – | 0.86% | 42 |
|
2021
Q4 | $880K | Sell |
14,364
-3,365
| -19% | -$206K | 0.86% | 42 |
|
2021
Q3 | $1.33M | Sell |
17,729
-551
| -3% | -$41.2K | 1.24% | 22 |
|
2021
Q2 | $1.69M | Buy |
+18,280
| New | +$1.69M | 1.58% | 16 |
|